Novel microorganism strain GM-020 of Lactobacillus rhamnosus and its use for treating obesity

• US 20050186189A1
• Filed: 10/04/2004
• Published: 08/25/2005
• Est. Priority Date: 02/19/2004
• Status: Abandoned Application

• Current Assignee: Genmont Biotech, Inc.
• Original Assignee: Genmont Biotech, Inc.
• Inventors: Hsu, Ching-Hsiang, Su, Wei-Chih
• Application Number:
  US10/956,138
• Publication Number:
  US 20050186189A1
• Time in Patent Office: Days
• US Class Current: 424/93.450
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 35/747 Lactobacilli, e.g. L. acidophilus or L. brevis
• CPC Class Codes: A61K 36/07 Basidiomycota, e.g. Cryptococcus
• CPC Class Codes: C12N 1/20 Bacteria; Culture media therefor
• CPC Class Codes: C12N 1/205 Bacterial isolates
• CPC Class Codes: C12R 2001/225 Lactobacillus

Abstract

The present invention provides an isolated microorganism strain, Lactobacillus rhamnosus GM-020, which is found to be effective in treating obesity and a complication thereof. The use of the Lactobacillus rhamnosus GM-020 in treating obesity and a complication thereof is also provided.

Claims

1-2. -2. (canceled)

3. A method for treating obesity or a complication thereof in a subject comprising:

administrating to said subject a composition comprising an isolated microorganism of the strain Lactobacillus rhamnosus GM-020, deposited at the China Center for Type Culture Collection under CCTCC No.;

CCTCC M 203098.

4. The method according to claim 3, wherein the composition further comprises Auricularia polytricha.

5. The method according to claim 3, wherein the complication is selected from the group consisting of hypercholesterolemia, atherosclerosis and coronary heart disease.

6. A method for treating obesity or a complication thereof in a subject comprising administrating to said subject a composition comprising an isolated microorganism of the strain Lactobacillus rhamnosus GM-020, deposited at the China Center for Type Culture Collection under CCTCC No.:

CCTCC M 203098 and Auricularia polytricha.

7. The method according to claim 6, wherein the complication is selected from the group consisting of hypercholesterolemia, atherosclerosis, coronary heart disease, fatty liver, and diabetes mellitus.

8-12. -12. (canceled)